SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
SOME STATISTICAL ISSUES IN PROJECT PRIORITIZATION IN THE PHARMACEUTICAL INDUSTRY
0 references·2 citing·7 second hop
SOME STATISTICAL ISSUES IN PROJECT PRIORITIZATION IN THE PHARMACEUTICAL INDUSTRY (1996)SOME STATISTICAL ISSUES IN PROJECT PRIORI…Optimal decision indices for R&D project evaluation in the pharmaceutical industry: Pearson index versus Gittins index (2006)Optimal decision indices for …Role of Pharmacoeconomic Analysis in R&D Decision Making (2005)Role of Pharmacoeconomic Anal…Bandit Processes and Dynamic Allocation Indices (1979)Quantitative Methods in the Planning of Pharmaceutical Research (1996)Research on management issues in the pharmaceutical industry: a literature review (2012)Predicting funded research project performance based on machine learning (2022)An economic approach to clinical trial design and research priority-setting (1996)Returns on Research and Development for 1990s New Drug Introductions (2002)The price of innovation: new estimates of drug development costs (2003)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2005Role of Pharmacoeconomic Analysis in R&D Decision Making62 cited
  • 2006Optimal decision indices for R&D project evaluation in the pharmaceutical industry: Pearson index versus Gittins index29 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work